About Me

WK Information’s purpose is to support clients to make informed optimal decisions. Our reports cover a variety of fields, from niche market to general market. Our consistent growth and ability to deliver in-depth analyses and market insight has engaged genuine.

Follow us


04 Aug

Global Cristobalite Market Insight

Global cristobalite will increase steadily over the next...

03 Aug

Global Gold Nanoparticles Market Insight

The Gold Nanoparticles is forecast to crazy increase...

26 Jul

Global Flue Gas Desulfurization Market Insight

The Flue Gas Desulfurization is forecast to steadily...

25 Jul

Global Epoxy Reactive Diluents Market Insight

According to the WK-chem Research “Global Epoxy Reactive...

04 Jan
Global Hyaluronic Acid Based Dermal Fillers Market Insight January 4, 2022 Comments

The Hyaluronic Acid Based Dermal Fillers is forecast to crazy increase over the next four years. According to the World Knowledge Information (WKI) “Global Hyaluronic Acid Based Dermal Fillers Professional Survey Report 2021, Forecast to 2026”, Hyaluronic acid dermal fillers are gaining popularity among dermatologists as well as patients.This has increased the sales of Hyaluronic acid dermal fillers on the market.The compound annual growth rate (CAGR) for the 2021-2026 period is projected to be 7.4% base on WKI regression analysis model.

Analysts’ Viewpoint:
“A worldwide increase in the aging population has also increased the demand for antiaging cosmetic and aesthetic treatments. Owing to its distinctive viscoelastic and moisturizing properties and lower toxicity levels, hyaluronic acid products are preferred for the growing demand for minimally invasive antiaging solutions.”said Becky Miller, Senior analyst, Chemical & Material Market Research Center in WKI.

Market insight:
Hyaluronic acid based dermal fillers are based on hyaluronic acid also known as hyaluronan, a clear substance that isnaturally produced in the human body.Existing market players operating in the market are focusing on constantinnovation and up-gradation of their product portfolio with new and efficient product offerings for better and accurateaesthetic outcomes for the patients.One of the critical reasons for the growth of the global hyaluronic acid-based dermal fillers market is the increasingdemand for aesthetic beauty, driven by the minimally invasive nature of the procedures and the increasing efficiencyof the hyaluronic acid based dermal fillers. Rise in awareness regarding hyaluronic acid based dermal fillers in bothdeveloping and developed nations, and the emergence of new products and the associated new indications such aslaugh lines, are also propelling the hyaluronic acid based dermal fillers market growth.

Competition Landscape:
The market is highly competitive with several multinational and regional players dominating the market. Key players are engaged in expanding their product portfolio and geographical presence. New product development and mergers and acquisitions are some of the strategies undertaken by hyaluronic acid dermal filler manufacturers. Competition in the market is primarily based on product innovation and quality, customer service, and pricing.
Manufacturers such as Allergan and Galderma have a strong product portfolio and are investing significantly to enhance their pipeline with new and innovative products. For instance, in September 2019, Allergan received FDA approval for VOLUMA XC with TSK STERiGLIDE cannula to be used in cheek augmentation. In October 2018, Galderma Laboratories invested in six new phase 2 and 4 clinical trials in the U.S. for new Restylane Lyft Dermal Filler.
Private companies such as Merz Pharmaceuticals and Laboratoires VIVACY are not only undertaking initiatives to launch novel products but are also gaining approvals for extended therapeutic areas of existing products. In 2018, Merz launched Belotero Lips for lip enhancement and treatment of perioral lines.
This WKI market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Hyaluronic Acid Based Dermal Fillers companies that include:Allergan; Galderma Laboratories L.P.; Merz Pharmaceuticals; Genzyme Corporation; Anika Therapeutics Inc.; LG Life Sciences, LTD (LG Chem); Bio plus Co. Ltd.; Sculpt Luxury Dermal Fillers Ltd; Bioxis Pharmaceutical; Sinclair Pharma; Laboratories Vivacy; and Bohus Biotech AB.

Segmentation of Hyaluronic Acid Based Dermal Fillers Market:
Based on the product, the market is categorized into single-phase products and duplex products. The single-phase fillers segment is expected to witness lucrative growth owing to multiple applications in skin and facial aesthetic procedures, comparatively fewer side effects, and rapid technological advancements for developing new fillers.Single-phase products are most preferred by dermatologists and consumers for correction of soft tissue facial deformities as the uncross-linked HA boosts elastin and collagen production that gives a youthful and healthy-looking glow to the skin. During the manufacturing process, single-phase products do not undergo the sizing technique—a process to breakdown the gel. Hylacross technology is used in the manufacturing of single-phase dermal fillers such as Juvederm Ultra, which results in product longevity with desirable effects.
Based on the application, the hyaluronic acid-based dermal fillers market is classified into wrinkle removal, lip augmentation, rhinoplasty, and others. The wrinkle removal segment held the largest market share. This can be attributed to the increasing trend of social networking websites, insistent peer pressure, and popularity of the procedure among women as well as men of all age groups. Moreover, hyaluronic acid-based dermal fillers are gaining popularity for the correction of face structure and shape.Hyaluronic acid fillers are also widely used for the correction of lip structure and shape or enhancement of lip volume. Launch of new and innovative products specially designed for lip augmentation is expected to boost the market. Scar correction, face contouring, cheek augmentation, and smoothing tear troughs are some of the other applications. Acne affects most of adolescents and a lot of the patients suffer from acne scars, making it a challenging cosmetic issue. As the prevalence of the disease is more, the scope of the treatment is also high.

Hyaluronic Acid Based Dermal Fillers Market: Regional Analysis
In terms of geography, the global Hyaluronic Acid Based Dermal Fillers market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa.
North America held the largest market share owing to the easy availability of products across the U.S. and Canada and increasing demand from middle-aged as well as young consumers. Hyaluronic acid dermal filler procedures were ranked second among noninvasive injectable procedures in the U.S.
The European market is driven by factors such as a rapidly aging population and increasing awareness among people about advanced aesthetic procedures. An increase in per capita income of countries such as Spain is another factor leading to an increase in the adoption of dermal fillers in the region.
The Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the high demand for cosmetic and aesthetic products from countries such as Japan, China, South Korea, Thailand, Australia, and India. This demand is expected to increase due to the growing influence of social media and increasing awareness regarding minimally invasive procedures for cosmetic and aesthetic medicinal treatments. Moreover, the availability of these products at a lower cost is likely to spur the regional market.
In Latin American countries such as Brazil, Mexico, Colombia, Venezuela, and Argentina, treatments involving the use of hyaluronic acid-based injectables are the fourth most widely performed nonsurgical aesthetic procedures. Also, medical tourism for dermal fillers is driving the market in this region. The selling price of hyaluronic acid-based dermal fillers is lower in Latin America, leading to an increase in the number of people traveling to this region for these procedures.

Cagr: 7.4%

Largest share area:North America
Largest share country:the Unite States